Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High-voltage activated calcium channels are essential multi-subunit membrane proteins that open in response to membrane depolarization, allowing calcium ions to enter cells along their electrochemical gradient. They are widely distributed and play crucial roles in cellular signaling and various physiological processes. Structurally, they consist of a pore-forming α₁ subunit, which contains the voltage-sensing machinery and drug/toxin-binding sites, and auxiliary subunits (α₂δ, β, γ). HVA channels require stronger depolarization to open compared to LVA channels. Subtypes include L-type (Cav1), P/Q-type (Cav2.1), N-type (Cav2.2), and R-type (Cav2.3), each with distinct properties and roles.
Drugs targeting HVA calcium channels primarily act as blockers or antagonists, preventing the influx of calcium ions into cells upon channel opening.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High-voltage activated calcium channels (HVA calcium channels).